Published: 30 Apr 2023 | Report Code: 10248388 | Pages: 258
Global Active Pharmaceutical Ingredients (API) Market will reach $ 386.2 billion by 2032, growing by 6.4% annually over 2022-2032, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in the geriatric population. Highlighted with 141 tables and 111 figures, this 258-page report “Global Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Global Active Pharmaceutical Ingredients (API) Market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include the identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Five Forces
The trend and outlook of the global market is forecast in an optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Global Active Pharmaceutical Ingredients (API) Market in every aspect of the classification from perspectives of Molecule, Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Region.
Based on Molecule, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Small Molecule APIs
• Large Molecule APIs
Based on Synthesis, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Synthetic API
o Branded Synthetic API
o Generic Synthetic API
• Biotech API
o By type
o Monoclonal Antibodies
o Recombinant Proteins
o Vaccines
o Other Biotech APIs
o By Category
o Innovative Biologic API
o Generic Biosimilar API
o By Expression
o Mammalian Expression
o Microbial Expression
o Yeast Expression
o Insect Expression
o Other Expression Technologies
• HPAPI
o Branded HPAPI
o Generic HPAPI
Based on Manufacturing Process, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Captive Manufacturing
o Branded Captive API
o Generic Captive API
• Merchant Manufacturing
o By Drug Type
o Branded Merchant API
o Generic Merchant API
o By Drug Synthesis
o Merchant Synthetic API
o Merchant Biotech API
By Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Orthopedics
• Other Applications
By Drug Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of all regional markets by country and split of each national market by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included. The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents: 1 Introduction 13 1.1 Industry Definition and Research Scope 13 1.1.1 Industry Definition 13 1.1.2 Research Scope 14 1.2 Research Methodology 17 1.2.1 Overview of Market Research Methodology 17 1.2.2 Market Assumption 18 1.2.3 Secondary Data 18 1.2.4 Primary Data 18 1.2.5 Data Filtration and Model Design 19 1.2.6 Market Size/Share Estimation 20 1.2.7 Research Limitations 21 1.3 Executive Summary 22 2 Market Overview and Dynamics 25 2.1 Market Size and Forecast 25 2.1.1 Impact of COVID-19 on World Economy 26 2.1.2 Impact of COVID-19 on the Market 29 2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 36 2.2 Major Growth Drivers 40 2.3 Market Restraints and Challenges 48 2.4 Emerging Opportunities and Market Trends 51 2.5 Porter’s Fiver Forces Analysis 55 3 Segmentation of Global Market by Molecule 59 3.1 Market Overview by Molecule 59 3.2 Small Molecule APIs 61 3.3 Large Molecule APIs 62 4 Segmentation of Global Market by Synthesis 63 4.1 Market Overview by Synthesis 63 4.2 Synthetic API 65 4.2.1 Branded Synthetic API 66 4.2.2 Generic Synthetic API 67 4.3 Biotech API 68 4.3.1 Biotech API by Drug Type 69 4.3.1.1 Monoclonal Antibodies 70 4.3.1.2 Recombinant Proteins 71 4.3.1.3 Vaccines 72 4.3.1.4 Other Biotech APIs 73 4.3.2 Biotech API by Category 74 4.3.2.1 Innovative Biologic API 75 4.3.2.2 Generic Biosimilar API 76 4.3.3 Biotech API by Expression Technology 77 4.3.3.1 Mammalian Expression 78 4.3.3.2 Microbial Expression 79 4.3.3.3 Yeast Expression 80 4.3.3.4 Insect Expression 81 4.3.3.5 Other Expression Technologies 82 4.4 HPAPI 83 4.4.1 Branded HPAPI 84 4.4.2 Generic HPAPI 85 5 Segmentation of Global Market by Manufacturing Process 86 5.1 Market Overview by Manufacturing Process 86 5.2 Captive Manufacturing 88 5.2.1 Branded Captive API 89 5.2.2 Generic Captive API 90 5.3 Merchant Manufacturing 91 5.3.1 Merchant Manufacturing by Drug Type 92 5.3.1.1 Branded Merchant API 93 5.3.1.2 Generic Merchant API 94 5.3.2 Merchant Manufacturing by Drug Synthesis 95 5.3.2.1 Merchant Synthetic API 96 5.3.2.2 Merchant Biotech API 97 6 Segmentation of Global Market by Therapeutic Application 98 6.1 Market Overview by Therapeutic Application 98 6.2 Infectious Diseases 100 6.3 Oncology 101 6.4 Ophthalmology 102 6.5 Cardiovascular Disorders 103 6.6 Central Nervous System 104 6.7 Pulmonary Disorders 105 6.8 Orthopedics 106 6.9 Other Applications 107 7 Segmentation of Global Market by Drug Type 108 7.1 Market Overview by Drug Type 108 7.2 Branded Prescription Drugs 110 7.3 Generic Prescription Drugs 111 7.4 OTC Drugs 112 8 Segmentation of Global Market by Region 113 8.1 Geographic Market Overview 2022-2032 113 8.2 North America Market 2022-2032 by Country 117 8.2.1 Overview of North America Market 117 8.2.2 U.S. 120 8.2.3 Canada 130 8.2.4 Mexico 132 8.3 European Market 2022-2032 by Country 134 8.3.1 Overview of European Market 134 8.3.2 UK 137 8.3.3 France 139 8.3.4 Germany 141 8.3.5 Spain 143 8.3.6 Italy 145 8.3.7 Russia 147 8.3.8 Rest of European Market 149 8.4 Asia-Pacific Market 2022-2032 by Country 151 8.4.1 Overview of Asia-Pacific Market 151 8.4.2 China 154 8.4.3 Japan 156 8.4.4 India 159 8.4.5 Australia 161 8.4.6 South Korea 163 8.4.7 Rest of APAC Region 165 8.5 South America Market 2022-2032 by Country 167 8.5.1 Argentina 170 8.5.2 Brazil 172 8.5.3 Chile 174 8.5.4 Rest of South America Market 176 8.6 MEA Market 2022-2032 by Country 177 8.6.1 UAE 180 8.6.2 Saudi Arabia 182 8.6.3 South Africa 184 8.6.4 Other National Markets 186 9 Competitive Landscape 187 9.1 Overview of Key Vendors 187 9.2 New Product Launch, Partnership, Investment, and M&A 190 9.3 Company Profiles 191 AbbVie Inc. 191 Astrazeneca 193 Aurobindo Pharma Ltd. 198 BASF 201 Bayer AG 204 Boehringer Ingelheim 208 Catalent Inc. 213 Dr. Reddy's Laboratories 216 F. Hoffmann-La Roche 218 GlaxoSmithKline plc 221 Lonza Group 226 Lupin Limited 230 Merck & Co., Inc. 233 Mylan NV 236 Novartis International AG 239 Pfizer Inc. 242 Sanofi 247 Sun Pharmaceutical Industries Ltd. 250 Teva Pharmaceutical Industries Ltd. 253 Thermo Fisher Scientific 255 Related Reports and Products 258
List of Tables: Table 1. Snapshot of Global Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2022-2032 23 Table 2. World Economic Outlook, 2021-2031 27 Table 3. World Economic Outlook, 2021-2023 28 Table 4. Scenarios for Economic Impact of Ukraine Crisis 37 Table 5. World Health Spending by Region, $ bn, 2013-2020 46 Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 47 Table 7. Main Product Trends and Market Opportunities in Global Active Pharmaceutical Ingredients (API) Market 51 Table 8. Global Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, $ bn 59 Table 9. Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 63 Table 10. Global Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2022-2032, $ bn 65 Table 11. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2022-2032, $ bn 69 Table 12. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2022-2032, $ bn 74 Table 13. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2022-2032, $ bn 77 Table 14. Global Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2022-2032, $ bn 83 Table 15. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 86 Table 16. Global Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2022-2032, $ bn 88 Table 17. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2022-2032, $ bn 92 Table 18. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2022-2032, $ bn 95 Table 19. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 98 Table 20. Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, $ bn 108 Table 21. Global Active Pharmaceutical Ingredients (API) Market by Region, 2022-2032, $ bn 114 Table 22. Leading National Active Pharmaceutical Ingredients (API) Market, 2022 and 2032, $ bn 116 Table 23. North America Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn 119 Table 24. U.S. Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 122 Table 25. U.S. Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 122 Table 26. U.S. Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 122 Table 27. Top 15 Countries Supplying API for Medicines Consumed in the US, 2019, ?sed on Dollar Value 124 Table 28. Canada Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 131 Table 29. Canada Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 131 Table 30. Canada Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 131 Table 31. Mexico Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 133 Table 32. Mexico Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 133 Table 33. Mexico Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 133 Table 34. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn 136 Table 35. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 138 Table 36. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 138 Table 37. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 138 Table 38. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 140 Table 39. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 140 Table 40. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 140 Table 41. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 142 Table 42. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 142 Table 43. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 142 Table 44. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 144 Table 45. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 144 Table 46. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 144 Table 47. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 146 Table 48. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 146 Table 49. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 146 Table 50. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 148 Table 51. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 148 Table 52. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 148 Table 53. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2022-2032, $ bn 150 Table 54. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn 153 Table 55. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 155 Table 56. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 155 Table 57. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 155 Table 58. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 158 Table 59. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 158 Table 60. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 158 Table 61. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 160 Table 62. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 160 Table 63. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 160 Table 64. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 162 Table 65. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 162 Table 66. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 162 Table 67. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 164 Table 68. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 164 Table 69. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 164 Table 70. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2022-2032, $ bn 166 Table 71. South America Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn 169 Table 72. Argentina Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 171 Table 73. Argentina Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 171 Table 74. Argentina Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 171 Table 75. Brazil Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 173 Table 76. Brazil Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 173 Table 77. Brazil Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 173 Table 78. Chile Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 175 Table 79. Chile Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 175 Table 80. Chile Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 175 Table 81. MEA Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn 179 Table 82. UAE Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 181 Table 83. UAE Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 181 Table 84. UAE Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 181 Table 85. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 183 Table 86. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 183 Table 87. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 183 Table 88. South Africa Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 185 Table 89. South Africa Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 185 Table 90. South Africa Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 185 Table 91. AbbVie Inc.: Company Snapshot 191 Table 92. AbbVie Inc.: Business Segmentation 192 Table 93. AbbVie Inc.: Product Portfolio 192 Table 94. Astrazeneca: Company Snapshot 193 Table 95. Aurobindo Pharma Ltd.: Company Snapshot 198 Table 96. Aurobindo Pharma Ltd.: Product Portfolio 199 Table 97. BASF: Company Snapshot 201 Table 98. BASF: Business Segmentation 202 Table 99. Bayer AG: Company Snapshot 204 Table 100. Bayer AG: Business Segmentation 205 Table 101. Bayer AG: Product Portfolio 205 Table 102. Boehringer Ingelheim: Company Snapshot 208 Table 103. Boehringer Ingelheim: Product Portfolio 209 Table 104. Catalent Inc.: Company Snapshot 213 Table 105. Catalent Inc.: Business Segmentation 214 Table 106. Catalent Inc.: Product Portfolio 214 Table 107. Dr. Reddy's Laboratories: Company Snapshot 216 Table 108. Dr. Reddy's Laboratories: Business Segmentation 216 Table 109. F. Hoffmann-La Roche: Company Snapshot 218 Table 110. F. Hoffmann-La Roche: Clinical Trial Service 218 Table 111. F. Hoffmann-La Roche: Business Segmentation 219 Table 112. F. Hoffmann-La Roche: Revenue by Region 219 Table 113. GlaxoSmithKline: Company Snapshot 221 Table 114. GlaxoSmithKline: Business Segmentation 222 Table 115. GlaxoSmithKline: Product Portfolio 223 Table 116. Lonza Group: Company Snapshot 226 Table 117. Lonza Group: Business Segmentation 227 Table 118. Lonza Group: Product Portfolio 227 Table 119. Lupin Limited: Company Snapshot 230 Table 120. Lupin Limited: Business Segmentation 231 Table 121. Merck & Co., Inc.: Company Snapshot 233 Table 122. Merck & Co., Inc.: Business Segmentation 234 Table 123. Mylan NV: Company Snapshot 236 Table 124. Mylan NV: Breakdown of Revenue by Region, 2022 237 Table 125. Mylan NV: Breakdown of Revenue by Product Category, 2022 237 Table 126. Novartis International AG: Company Snapshot 239 Table 127. Novartis International AG: Business Segmentation 240 Table 128. Pfizer Inc.: Company Snapshot 242 Table 129. Pfizer Inc.: Business Segmentation 243 Table 130. Pfizer Inc.: Breakdown of Revenue by Product Category 243 Table 131. Pfizer Inc.: Breakdown of Revenue by Region 244 Table 132. Pfizer Inc.: Product Portfolio 244 Table 133. Sanofi: Company Snapshot 247 Table 134. Sanofi: Business Segmentation 248 Table 135. Sanofi: Breakdown of Revenue by Region 248 Table 136. Sun Pharmaceutical Industries Limited: Company Snapshot 250 Table 137. Teva Pharmaceutical Industries Ltd.: Company Snapshot 253 Table 138. Teva Pharmaceutical Industries Ltd.: Business Segmentation 254 Table 139. Thermo Fisher Scientific: Company Snapshot 255 Table 140. Thermo Fisher Scientific: Breakdown of Revenue by Business Segment, 2020, %6 Table 141. Thermo Fisher Scientific: Breakdown of Revenue by Region, 2020, %6
List of Figures: Figure 1. Research Method Flow Chart 17 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 20 Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 22 Figure 4. Global Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 25 Figure 5. Impact of COVID-19 on Business 29 Figure 6. Primary Drivers and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market 40 Figure 7. GDP per capita in the World, 1960-2022, $ thousand 43 Figure 8. Leading Causes of Death in the World, 2000 and 2019, million 44 Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 45 Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 45 Figure 11. Primary Restraints and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market 48 Figure 12. Investment Opportunity Analysis 52 Figure 13. Porter’s Fiver Forces Analysis of Global Active Pharmaceutical Ingredients (API) Market 55 Figure 14. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, % of Revenue 60 Figure 15. Global Addressable Market Cap in 2023-2032 by Molecule, Value ($ bn) and Share (%) 60 Figure 16. Global Active Pharmaceutical Ingredients (API) Market by Molecule: Small Molecule APIs, 2022-2032, $ bn 61 Figure 17. Global Active Pharmaceutical Ingredients (API) Market by Molecule: Large Molecule APIs, 2022-2032, $ bn 62 Figure 18. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, % of Revenue 63 Figure 19. Contribution to Global 2023-2032 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%) 64 Figure 20. Global Active Pharmaceutical Ingredients (API) Market by Synthesis: Synthetic API, 2022-2032, $ bn 65 Figure 21. Global Active Pharmaceutical Ingredients (API) Market by Synthetic API: Branded Synthetic API, 2022-2032, $ bn 66 Figure 22. Global Active Pharmaceutical Ingredients (API) Market by Synthetic API: Generic Synthetic API, 2022-2032, $ bn 67 Figure 23. Global Active Pharmaceutical Ingredients (API) Market by Synthesis: Biotech API, 2022-2032, $ bn 68 Figure 24. Global Biotech API Market by Drug Type: Monoclonal Antibodies, 2022-2032, $ bn 70 Figure 25. Global Biotech API Market by Drug Type: Recombinant Proteins, 2022-2032, $ bn 71 Figure 26. Global Biotech API Market by Drug Type: Vaccines, 2022-2032, $ bn 72 Figure 27. Global Biotech API Market by Drug Type: Other Biotech APIs, 2022-2032, $ bn 73 Figure 28. Global Biotech API Market by Category: Innovative Biologic API, 2022-2032, $ bn 75 Figure 29. Global Biotech API Market by Category: Generic Biosimilar API, 2022-2032, $ bn 76 Figure 30. Global Biotech API Market by Expression Technology: Mammalian Expression, 2022-2032, $ bn 78 Figure 31. Global Biotech API Market by Expression Technology: Microbial Expression, 2022-2032, $ bn 79 Figure 32. Global Biotech API Market by Expression Technology: Yeast Expression, 2022-2032, $ bn 80 Figure 33. Global Biotech API Market by Expression Technology: Insect Expression, 2022-2032, $ bn 81 Figure 34. Global Biotech API Market by Expression Technology: Other Expression Technologies, 2022-2032, $ bn 82 Figure 35. Global Active Pharmaceutical Ingredients (API) Market by Synthesis: HPAPI, 2022-2032, $ bn 83 Figure 36. Global Active Pharmaceutical Ingredients (API) Market by HPAPI: Branded HPAPI, 2022-2032, $ bn 84 Figure 37. Global Active Pharmaceutical Ingredients (API) Market by HPAPI: Generic HPAPI, 2022-2032, $ bn 85 Figure 38. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, % of Revenue 86 Figure 39. Contribution to Global 2023-2032 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%) 87 Figure 40. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Captive Manufacturing, 2022-2032, $ bn 88 Figure 41. Global Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Branded Captive API, 2022-2032, $ bn 89 Figure 42. Global Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Generic Captive API, 2022-2032, $ bn 90 Figure 43. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Merchant Manufacturing, 2022-2032, $ bn 91 Figure 44. Global API Merchant Manufacturing Market by Drug Type: Branded Merchant API, 2022-2032, $ bn 93 Figure 45. Global API Merchant Manufacturing Market by Drug Type: Generic Merchant API, 2022-2032, $ bn 94 Figure 46. Global API Merchant Manufacturing Market by Drug Synthesis: Merchant Synthetic API, 2022-2032, $ bn 96 Figure 47. Global API Merchant Manufacturing Market by Drug Synthesis: Merchant Biotech API, 2022-2032, $ bn 97 Figure 48. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, % of Revenue 98 Figure 49. Contribution to Global 2023-2032 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%) 99 Figure 50. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Infectious Diseases, 2022-2032, $ bn 100 Figure 51. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Oncology, 2022-2032, $ bn 101 Figure 52. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Ophthalmology, 2022-2032, $ bn 102 Figure 53. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Cardiovascular Disorders, 2022-2032, $ bn 103 Figure 54. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Central Nervous System, 2022-2032, $ bn 104 Figure 55. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Pulmonary Disorders, 2022-2032, $ bn 105 Figure 56. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Orthopedics, 2022-2032, $ bn 106 Figure 57. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Other Applications, 2022-2032, $ bn 107 Figure 58. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, % of Revenue 108 Figure 59. Contribution to Global 2023-2032 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%) 109 Figure 60. Global Active Pharmaceutical Ingredients (API) Market by Drug Type: Branded Prescription Drugs, 2022-2032, $ bn 110 Figure 61. Global Active Pharmaceutical Ingredients (API) Market by Drug Type: Generic Prescription Drugs, 2022-2032, $ bn 111 Figure 62. Global Active Pharmaceutical Ingredients (API) Market by Drug Type: OTC Drugs, 2022-2032, $ bn 112 Figure 63. Global Market Snapshot by Region 113 Figure 64. Geographic Spread of Worldwide Active Pharmaceutical Ingredients (API) Market, 2022-2032, % of Revenue 114 Figure 65. Contribution to Global 2023-2032 Cumulative Revenue by Region, Value ($ bn) and Share (%) 115 Figure 66. North American Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 118 Figure 67. Breakdown of North America Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue 118 Figure 68. Contribution to North America 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%) 119 Figure 69. U.S. Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 121 Figure 70. Manufacturing Sites of APIs for U.S. Market by Country or Region, 126 Figure 71. Number and Percentage of API Facilities for the 370 U.S. Marketed Drugs on the 2019 WHO Essential Medicines List 126 Figure 72. Number and Percentage of API Facilities for the 370 U.S. Marketed Drugs on the 2019 WHO Essential Medicines List 127 Figure 73. Canada Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 130 Figure 74. Active Pharmaceutical Ingredients (API) Market in Mexico, 2022-2032, $ bn 132 Figure 75. European Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 135 Figure 76. Breakdown of European Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue 135 Figure 77. Contribution to Europe 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%) 136 Figure 78. Active Pharmaceutical Ingredients (API) Market in UK, 2022-2032, $ bn 137 Figure 79. Active Pharmaceutical Ingredients (API) Market in France, 2022-2032, $ bn 139 Figure 80. Active Pharmaceutical Ingredients (API) Market in Germany, 2022-2032, $ bn 141 Figure 81. Active Pharmaceutical Ingredients (API) Market in Spain, 2022-2032, $ bn 143 Figure 82. Active Pharmaceutical Ingredients (API) Market in Italy, 2022-2032, $ bn 145 Figure 83. Active Pharmaceutical Ingredients (API) Market in Russia, 2022-2032, $ bn 147 Figure 84. Active Pharmaceutical Ingredients (API) Market in Rest of Europe, 2022-2032, $ bn 149 Figure 85. Asia-Pacific Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 152 Figure 86. Breakdown of APAC Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue 152 Figure 87. Contribution to APAC 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%) 153 Figure 88. Active Pharmaceutical Ingredients (API) Market in China, 2022-2032, $ bn 154 Figure 89. Active Pharmaceutical Ingredients (API) Market in Japan, 2022-2032, $ bn 157 Figure 90. Active Pharmaceutical Ingredients (API) Market in India, 2022-2032, $ bn 159 Figure 91. Active Pharmaceutical Ingredients (API) Market in Australia, 2022-2032, $ bn 161 Figure 92. Active Pharmaceutical Ingredients (API) Market in South Korea, 2022-2032, $ bn 163 Figure 93. Active Pharmaceutical Ingredients (API) Market in Rest of APAC, 2022-2032, $ bn 165 Figure 94. South America Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 168 Figure 95. Breakdown of South America Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue 168 Figure 96. Contribution to South America 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%) 169 Figure 97. Active Pharmaceutical Ingredients (API) Market in Argentina, 2022-2032, $ bn 170 Figure 98. Active Pharmaceutical Ingredients (API) Market in Brazil, 2022-2032, $ bn 172 Figure 99. Active Pharmaceutical Ingredients (API) Market in Chile, 2022-2032, $ bn 174 Figure 100. Active Pharmaceutical Ingredients (API) Market in Rest of South America, 2022-2032, $ bn 176 Figure 101. Active Pharmaceutical Ingredients (API) Market in MEA, 2022-2032, $ bn 178 Figure 102. Breakdown of MEA Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue 178 Figure 103. Contribution to MEA 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%) 179 Figure 104. Active Pharmaceutical Ingredients (API) Market in UAE, 2022-2032, $ bn 180 Figure 105. Active Pharmaceutical Ingredients (API) Market in Saudi Arabia, 2022-2032, $ bn 182 Figure 106. Active Pharmaceutical Ingredients (API) Market in South Africa, 2022-2032, $ bn 184 Figure 107. Growth Stage of Global Active Pharmaceutical Ingredients (API) Industry over the Forecast Period 187 Figure 108. AstraZeneca: Breakdown of Revenue by Therapy Area, 2022 194 Figure 109. AstraZeneca: Breakdown of Revenue by Region, 2022 194 Figure 110. Boehringer Ingelheim: Revenue by Business Segment, 2019-2022 209 Figure 111. Boehringer Ingelheim: R&D Investement, 2019-2022 210
Selected Key Players: AbbVie Inc. Astrazeneca Aurobindo Pharma Ltd. BASF Bayer AG Boehringer Ingelheim Catalent Inc. Dr. Reddy's Laboratories F. Hoffmann-La Roche GlaxoSmithKline plc Lonza Group Lupin Limited Merck & Co., Inc. Mylan NV Novartis International AG Pfizer Inc. Sanofi Sun Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. Thermo Fisher Scientific (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)